Category Archives: News

J&J files new Concerta lawsuit against Impax Labs Impax Laboratories Inc. said Friday it received a second patent lawsuit from Johnson & Johnson’s Alza Corp. division related to Impax’s proposed generic version of drug Concerta, which treats the attention deficit … Continue reading →

Georgia joins $44.3 million pharmaceutical settlement Georgia has joined other states and the U.S. government in reaching a $44.3 million settlement with the pharmaceutical manufacturer EMD Serono Inc., the state Attorney General’s Office said Thursday. The agreement settles allegations that … Continue reading →

UPDATE 1-Cephalon profit misses, company likes Teva deal * Q1 adjusted EPS $1.98 vs Street view $2.04 * Revenue $745.1 million * Says Teva offer provides maximum shareholder value NEW YORK, May 3 (Reuters) – Cephalon Inc (CEPH.O), which this … Continue reading →

Government ‘politicising’ PBS process Health groups say cancer patients and people with schizophrenia are among those who will be affected by the Federal Government’s decision to delay subsidising some medicines. The Government has delayed putting several medicines on the Pharmaceutical … Continue reading →

UPDATE 1-Par Pharmaceutical settles drug pricing lawsuits Says settlement will remove major damages and trials (Follows alerts) (Reuters) – Par Pharmaceutical Cos Inc said it settled drug pricing lawsuits against it that allegedly caused government entities to pay inflated reimbursements … Continue reading →

The Rise Of The Pharmaceutical Un-Sales Force In a variation on the old saying “if you can’t beat ‘em, join ‘em,” a number of states have initiated programs where purportedly independent clinicians, pharmacists and other medical personnel pay visits to … Continue reading →

FDA approves Taro’s Canadian pharmaceutical facility Taro Pharmaceutical Industries Ltd. (Pink Sheets: TAROF) can resume regular production at its Canadian manufacturing facility, after the US Food and Drug Administration (FDA) approved the facility, following a re inspection of the site … Continue reading →

Bayer Responds to Studies Linking Birth Control Pills to Blood Clots Following two studies that claim hormones used in newer birth control pills could put women at a greater risk of developing blood clots, Bayer HealthCare Pharmaceuticals, Inc. — who … Continue reading →

Cumberland Pharmaceuticals acquires drug candidate from Vanderbilt Cumberland Pharmaceuticals Inc. said Tuesday it has agreed to acquire rights to a molecule named ifetroban that it plans to test as a potential in-hospital treatment for a condition that involves progressive kidney … Continue reading →

Legal Help for Mothers Who Took Antiepileptic Meds During Pregnancy Taking antiepileptic or anticonvulsant medication such Depakote or Depakene to treat epilepsy, bipolar episodes of manic depression, and migraine headaches, during pregnancy may lead to birth defects. (PRWEB) April 20, … Continue reading →